Delivery Order 36F79720D0213-36C25021F0135
Award Date 10/29/20
Potential Completion Date 11/30/20
Potential Value $30K
Federal Agency
Awardee
Ultimate Awardee
Not listed NAICS Category
PSC Category
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Ann Arbor, MI 48105, USA
Solicitation Procedures
Multiple Award, Fair Opportunity
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 19 awarded a $39,754.84 firm fixed price delivery order to Servier Pharmaceuticals LLC of Boston, Massachusetts for the drug ONCASPAR. The contract has a period of performance through May 15, 2020 and was awarded on May 8, 2020 without a set-aside designation. Servier Pharmaceuticals LLC will provide the specified pharmaceutical to the VA network to support healthcare services for veterans in...
- Servier Pharmaceuticals LLC was awarded a delivery order against the Pharmaceuticals and Drugs Federal Supply Schedule by the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 22. The $13,821.79 firm fixed price order is for one unit of 750U PegasparGase, also known as Oncaspar, to be delivered to a location in San Diego, California by December 2, 2021. The delivery order was issued on November 4, 2021 under Master GSA Schedule FSS-61-IB, which...
- This federal contract award is for the supply of Oncaspar 750U/ML (PF) INJ,SOLN,5ML VIL, a specialty oncology medication, to the Department of Veterans Affairs (VA). The contract was awarded to Servier Pharmaceuticals LLC, a for-profit pharmaceutical company, under a Blanket Purchase Agreement (BPA) with the VA National Acquisition Center. The BPA has a ceiling value of $27,643.58 and aims to streamline the procurement of this chemotherapy agent to support cancer treatment programs for veterans....
- This delivery order against the Pharmaceuticals and Drugs Federal Supply Schedule, awarded by the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 22, is for an emergency pharmaceutical order of 84mg Eliglustat Cerdelga tablets from Genzyme Corporation. The $20,049.02 firm fixed price order issued to Genzyme Therapeutics Division, a division of Sanofi Genzyme, will supply the needed medication to the Veterans Integrated Service Network 22 by...
- This is a firm fixed-price delivery order awarded by the Department of Veterans Affairs (VA) Veterans Integrated Service Network 21 (VISN 21) to Genzyme Corporation, doing business as Sanofi Genzyme, under the Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB) contract. The $89,094.00 order is for the delivery of various specialty pharmaceutical products, including Eliglustat (Cerdelga), Lemtrada, and Caprelsa (vandetanib), to support treatment programs for veterans. Genzyme...
- <p>This is a $3,009.00 firm fixed price purchase order contract awarded by the Veterans Integrated Service Network 15 of the U.S. Department of Veterans Affairs to The Pharmaceutical Source LLC, a veteran-owned limited liability company, for the delivery of pharmaceuticals. The contract does not have a set-aside designation and was awarded on July 12, 2013 with a completion date of July 24, 2013. No information about major subcontractors or a larger contract vehicle was provided.</p>
- The Department of Veterans Affairs Veterans Health Administration awarded a $11,882.10 delivery order against Genzyme Corporation Sanofi Genzyme Division's Pharmaceuticals and Drugs GSA Schedule contract. Under this firm fixed price order, Genzyme will provide CAPRELSA 100MG to support VHA programs. Performance will take place in Cambridge, Massachusetts over a two week period in November and December 2023. The award utilizes Genzyme's GSA Pharmaceuticals and Drugs Schedule, a multiple award...
- The Department of Veterans Affairs (VA) Veterans Health Administration awarded a firm fixed-price purchase order to Sterisyn Inc., a self-certified small disadvantaged business, for $142,905.00 to provide pharmaceutical products to support VA healthcare programs for veterans. This order was placed under Sterisyn's existing Federal Supply Schedule (FSS) contract with the VA, which has a potential value of $360,000 through April 2024 and allows the company to provide pharmaceuticals, drugs, and...
- This is a federal contract award for the delivery of the pharmaceutical product CERDELGA to the Department of Veterans Affairs (VA) Veterans Health Administration. The contract was awarded to the prime contractor Genzyme Corporation, a division of Sanofi Genzyme, on a firm fixed price basis. The contract has a potential value of $106,943.55 and was issued as a delivery order against Genzyme's existing Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB) contract with the VA. The...
- This is a firm-fixed-price delivery order awarded by the Department of Veterans Affairs' (VA) Veterans Integrated Service Network 20 to Takeda Pharmaceuticals America, Inc., a foreign-owned, for-profit pharmaceutical manufacturer. The $27,913.44 order was placed against Takeda's General Services Administration (GSA) Schedule 61-IB for Pharmaceuticals and Drugs and has an ultimate completion date of August 19, 2024. The order is for the delivery of emergency pharmaceutical products,...